(VIANEWS) – Liberty All (ASG), Western Asset Bond Fund Share of Beneficial Interest (WEA), PCTEL (PCTI) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Liberty All (ASG) | 8.38% | 2023-08-16 03:06:08 |
| Western Asset Bond Fund Share of Beneficial Interest (WEA) | 7.48% | 2023-08-20 22:44:07 |
| PCTEL (PCTI) | 5.49% | 2023-08-25 11:09:07 |
| Bristol (BMY) | 3.67% | 2023-08-30 09:00:05 |
| AvalonBay Communities (AVB) | 3.64% | 2023-08-29 10:34:54 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Liberty All (ASG) – Dividend Yield: 8.38%
Liberty All’s last close was $5.20, 20.85% below its 52-week high of $6.57. Intraday change was -0.95%.
Liberty All-Star Growth Fund, Inc. is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. It is co-managed by Weatherbie Capital, LLC, Congress Asset Management Company, and Sustainable Growth Advisers, LP. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Composite Index, Russell 3000 Growth Index, and the S&P 500 Index. It conducts in-house research to make its investments. The fund was previously known as Charles Allmon Trust, Inc. Liberty All-Star Growth Fund, Inc. was formed on March 14, 1986 and is domiciled in the United States.
Earnings Per Share
As for profitability, Liberty All has a trailing twelve months EPS of $-2.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.15%.
Volume
Today’s last reported volume for Liberty All is 131163 which is 35.19% below its average volume of 202387.
More news about Liberty All.
2. Western Asset Bond Fund Share of Beneficial Interest (WEA) – Dividend Yield: 7.48%
Western Asset Bond Fund Share of Beneficial Interest’s last close was $10.59, 10.25% under its 52-week high of $11.80. Intraday change was 0.86%.
Western Asset Premier Bond Fund is a closed-ended fixed income mutual fund launched and managed by Western Asset Management Company. The fund is co-managed by Western Asset Management Company Limited, Western Asset Management Company Pte. Ltd., and Western Asset Management Company Ltd. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade bonds, including corporate bonds, U.S. government and agency securities, and mortgage related securities. It seeks to maintain an average duration of around two to three years with an average credit quality of BBB. The fund benchmarks the performance of its portfolio against the Barclays Capital U.S. Corporate High Yield Index and the Barclays Capital U.S. Credit Index. Western Asset Premier Bond Fund was formed on March 28, 2002 and is domiciled in the United States.
Earnings Per Share
As for profitability, Western Asset Bond Fund Share of Beneficial Interest has a trailing twelve months EPS of $-2.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.99%.
Volume
Today’s last reported volume for Western Asset Bond Fund Share of Beneficial Interest is 22417 which is 35.32% below its average volume of 34662.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 12.94M for the twelve trailing months.
Moving Average
Western Asset Bond Fund Share of Beneficial Interest’s worth is below its 50-day moving average of $10.66 and above its 200-day moving average of $10.55.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 22, 2023, the estimated forward annual dividend rate is 0.79 and the estimated forward annual dividend yield is 7.48%.
More news about Western Asset Bond Fund Share of Beneficial Interest.
3. PCTEL (PCTI) – Dividend Yield: 5.49%
PCTEL’s last close was $4.02, 29.23% under its 52-week high of $5.68. Intraday change was -0.25%.
PCTEL, Inc., together with its subsidiaries, provides industrial Internet of Thing devices (IoT), antenna systems, and test and measurement solutions worldwide. The company designs and manufactures precision antennas and industrial IoT devices that are deployed in small cells, enterprise Wi-Fi access points, fleet management and transit systems, and in equipment and devices for the industrial IoT. Its antenna portfolio includes Wi-Fi, Bluetooth, land mobile radio, tetra, global navigation satellite systems, cellular, industrial, scientific, medical, long range, and combination antenna solutions for used in public safety and military communications, utilities and energy, precision agriculture, smart traffic management, electric vehicle charging stations, embedded vehicles, forestry machinery, and off-road vehicles, as well as offers engineering design services. The company's industrial IoT devices include access points, radio modules, sensor communication modules, and wireless communication sensors for used in utilities and smart grid, oil and gas, manufacturing, logistics, industrial automation, smart metering, and asset tracking markets. It also offers radio frequency (RF) test and measurement products that enhance the performance of wireless networks with a focus on LTE, public safety, and 5G technologies for cellular testing, public safety and private radio network testing, federal government communications testing, and indoor building network testing applications. In addition, the company provides a cloud-based reporting platform for public safety to manage the data collection process and access final reports through an online map-based interface. It supplies its products to wireless equipment distributors, public and private carriers, wireless infrastructure providers, and value-added resellers, as well as original equipment manufacturers. PCTEL, Inc. was incorporated in 1994 and is headquartered in Bloomingdale, Illinois.
Earnings Per Share
As for profitability, PCTEL has a trailing twelve months EPS of $0.33.
PE Ratio
PCTEL has a trailing twelve months price to earnings ratio of 12.15. Meaning, the purchaser of the share is investing $12.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.49%.
Volume
Today’s last reported volume for PCTEL is 5015 which is 88.79% below its average volume of 44746.
More news about PCTEL.
4. Bristol (BMY) – Dividend Yield: 3.67%
Bristol’s last close was $62.85, 22.83% below its 52-week high of $81.44. Intraday change was -0.13%.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $3.76.
PE Ratio
Bristol has a trailing twelve months price to earnings ratio of 16.69. Meaning, the purchaser of the share is investing $16.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.66%.
Sales Growth
Bristol’s sales growth is negative 0.8% for the present quarter and negative 0.2% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 5, 2023, the estimated forward annual dividend rate is 2.28 and the estimated forward annual dividend yield is 3.67%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Bristol’s EBITDA is 3.54.
Previous days news about Bristol
- Bristol myers (bmy) gets FDA nod for reblozyl label expansion. According to Zacks on Tuesday, 29 August, "The approval of new drugs and the label expansion of existing ones will enable Bristol Myers to diversify its product base and offset the slowdown in top-line growth, as Revlimid and Eliquis (in Canada and the U.K.) face generic competition."
More news about Bristol.
5. AvalonBay Communities (AVB) – Dividend Yield: 3.64%
AvalonBay Communities’s last close was $183.92, 14.9% under its 52-week high of $216.11. Intraday change was 0.1%.
As of June 30, 2023, the Company owned or held a direct or indirect ownership interest in 294 apartment communities containing 88,659 apartment homes in 12 states and the District of Columbia, of which 18 communities were under development and one community was under redevelopment. The Company is an equity REIT in the business of developing, redeveloping, acquiring and managing apartment communities in leading metropolitan areas in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California, as well as in the Company's expansion regions of Raleigh-Durham and Charlotte, North Carolina, Southeast Florida, Dallas and Austin, Texas, and Denver, Colorado.
Earnings Per Share
As for profitability, AvalonBay Communities has a trailing twelve months EPS of $8.91.
PE Ratio
AvalonBay Communities has a trailing twelve months price to earnings ratio of 20.48. Meaning, the purchaser of the share is investing $20.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11%.
Volatility
AvalonBay Communities’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.45%, a negative 0.07%, and a positive 0.93%.
AvalonBay Communities’s highest amplitude of average volatility was 0.45% (last week), 0.75% (last month), and 0.93% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
AvalonBay Communities’s EBITDA is 12.3.
More news about AvalonBay Communities.
